A CRISPR Approach to Genetic Medicine

On Episode 6 of GEN Live, sponsored by Synthego, we’ll discuss with a pair of talented genome editing pioneers how CRISPR and allied technologies are showing promise for the treatment and diagnosis of genetic diseases and providing new clues to combat the COVID-19 pandemic.

A Beacon for Rapid Antibody Discovery against Difficult Targets

In this GEN webinar, our panelists from Genovac, will present case studies of how they have overcome these antibody discovery and development challenges by leveraging their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.
embryonic stem cells

Optimizing Biotherapeutic Cell Lines for Continuous Manufacturing

In this GEN Webinar, sponsored by Horizon, we will hear from Dr. Jeff McGrew, Scientific Director at Just–Evotec Biologics, who has used the CHOSOURCE™ GS knockout cell line to develop high producing cell lines rapidly.
Vials and syringe with world map in background

Leveraging Platforms to Create Vaccinesat Pandemic Speed

Originally Aired: November 17, 2020Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Hand is inserting sequence of DNA. Genetic engineering, GMO and Gene manipulation concept.

A Conversation with Jennifer Doudna,2020 Nobel Laureate

The GEN/RFS “Women in Science” series is thrilled to host Jennifer Doudna in a live, candid “fireside chat”. Join Jennifer and some special guests for conversation and celebration of a truly groundbreaking scientist.
Adeno-associated virus

Scalable Plasmid-Free AAV Manufacturing

In this GEN webinar, Dr. Ryan Cawood describes how rethinking AAV manufacture “from the ground up”, allowed OXGENE™ to manipulate AAV’s natural relationship with adenovirus to address these challenges with their novel technology. The webinar will take a deep dive into the data behind this new technology, demonstrating how using these vectors can give a 40-fold improvement in AAV2 yield, alongside a 2000- fold increase in particle infectivity, establishing the potential for reduced cost of goods and improved safety for AAV based gene therapies.
petri dishes

The Empowerment of Having a Lab of One’s Own: Continued Research on Cholera, Climate,...

In this webinar—the second in the “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—pioneering microbiologist and the first woman to lead the National Science Foundation, Rita Colwell, PhD, discusses her early work in bacteriology and discoveries about how cholera survives between epidemics, with its continuing relevance today in addressing contagion, ocean science , and climate change.

Traveling through Space and Time: Trajectories of Our Most Powerful Immune Cells

Immune medicines, across cancers, infectious disease, and inflammatory disease, hold our closest promise to lasting curative therapies. In this sponsored webinar, IsoPlexis and various researchers will speak about the shift in space and time towards ‘Smaller’ to target our most powerful single cells, in order to accelerate timelines for finding these cures.

The Great Convergence: How Biology and Engineering Unite to Reshape our World

In this webinar—the third in the “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—renowned neuroscientist Dr. Susan Hockfield, who served as president of MIT from 2004–2012, will share her views of the future that she lays out in her recent book, The Age of Living Machines: How Biology Will Build the Next Technology Revolution.
webinar lead image

Biomanufacturing Assumes Central Role in Cell and Gene Therapies

In this GEN Keynote webinar, sponsored by Absorption Systems, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research (CBER) at the FDA, will share how CBER is providing oversight to organizations during the critical developmental and manufacturing stages for biological products, as well as throughout the product life cycle.

Recently Featured

Scroll Up